Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company specializing in the development and commercialization of treatments for rare diseases and unmet medical needs, is making significant ...

Researchers with City of Hope and MSK have created a tool that uses machine learning to assess a non-Hodgkin lymphoma (NHL) ...

Lymphoma is a symptom of swelling of the body due to problems in the circulation of lymph fluid through the lymphatic vessels ...

Takeda's Adcetris has become the first drug recommended for routine NHS use as a treatment for previously untreated ...

Cancer Center have created a tool that uses machine learning to assess a non-Hodgkin lymphoma (NHL) patient's likely response ...

From today, adults with advanced Hodgkin lymphoma have access to a new treatment, after we recommended brentuximab vedotin (brand name Adcetris) in combination with other therapies for routine NHS use ...

Dave Coulier's cancer is in remission! A rep for the 65-year-old 'Full House' actor confirmed that he was cancer-free after a ...

It usually responds well to treatment and is often cured. About one in five people with lymphoma have follicular lymphoma. This is a slow-growing form that mainly affects older adults. It might ...

As a lymphoma survivor, I struggle with the positivity trap — sometimes, I just want my fears validated instead of being ...

Soligenix is enrolling patients in its FLASH2 study, with a formal interim analysis anticipated early in 2026. <li /> SNGX's HyBryte is a ...